Background Invasive meningococcal disease clusters occur among university students and
may reflect higher carriage prevalence among this population. We aimed to measure …

Nel Piano Nazionale di Prevenzione Vaccinale 2012-2014 (PNPV 2012-2014)[1], l'Health
Technology Assessment (HTA) è stata identificata come l'approccio migliore per valutare …

Introduction: Meningococcal serogroup B disease (MenB) is endemic in the UK and
continues to cause the majority of invasive meningococcal disease. Two broadly protective …

Meningitis is an inflammation of the meninges, which are the three membranes that cover
the brain and the spinal cord; which occurs when the fluid surrounding the meninges …

We aimed to evaluate immunogenicity and adverse events (AEs) after a booster dose of
Meningococcal C conjugated (MCC) vaccine in HIV-infected children and adolescents, who …

Objective To describe cases of invasive meningococcal disease (IMD) in women of
childbearing age and to estimate the disease incidence and relative risk of IMD in pregnant …

中国上市的脑膜炎球菌疫苗包括脑膜炎球菌多糖疫苗, 脑膜炎球菌多糖结合疫苗和联合疫苗,
不同生产企业的脑膜炎球菌多糖结合疫苗的免疫程序有所不同, 给实际接种工作带来困扰 …

Chronic meningococcemia is a rare manifestation of meningococcal disease, characterized
by a period of more than one week of intermittent or continuous fever, arthralgia and skin …

Neisseria meningitidis, also known as the meningococcus, is a human-specific pathogen
that commonly colonises the nasopharynx without causing disease. For reasons unknown …

1Division of Bacterial Diseases, National Center for Immunization and Respiratory
Diseases, Centers for Disease Control and Prevention; 2Logistics Health Inc., La Crosse …